Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant kallikrein inhibitor

EU orphan designation number: EU/3/09/712   
Active ingredient: Recombinant kallikrein inhibitor
Indication: Treatment of Netherton syndrome
Sponsor: Dermadis S.A.S.
Technopole d’Archamps, Bâtiment Le Forum II, 74160 Archamps, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/02/2010 Orphan designation EMEA/OD/106/09 (2010)712 of 29/01/2010
13/01/2012 Transfer of orphan designation EMEA/OD/106/09/T/01 (2012)136 of 11/01/2012